Overview

Funded Cooperative Groups (CGs) and funded Community Clinical Oncology Program (CCOP) Research Bases are invited to apply for funding to support essential biomarker, imaging, and quality of life studies with or without a Cost-Effectiveness Analysis (CEA) proposal which are associated with clinical trial concepts.

Integral and/or integrated studies associated with Phase 3 therapeutic trials, cancer prevention trials, and primary symptom management trials are eligible. Only randomized Phase 3 clinical trials are eligible for CEA proposals. Funding support for Phase 2 concepts is limited to large (≥100 patients), randomized Phase 2 concepts for therapeutic trials with a control arm and an integral study(ies).

This is an "open competition" announcement with no specific receipt date.